Views & Analysis Evolving immunotherapy strategies in NSCLC Status of immunotherapies in non-small cell lung cancer (NSCLC).
News Roche raises outlook for 2017 following strong launches The launch of three new products with blockbuster potential helped increase Roche’s revenues 5% in
Views & Analysis ASCO 2017: Breast cancer next target for Keytruda Immunotherapy combinations will be the focus - but attention is shifting towards these agents proving their overall survival benefits.
News BMS looks to Opdivo + vaccine combo for non-PD-L1 lung cance... Bristol-Myers Squibb is teaming up with France’s Transgene to combine Opdivo with investigational therapeutic vaccine TG4010 in lung cancer.
News Roche’s Alecensa beats Xalkori in lung cancer head-to-head Roche’s new targeted lung cancer treatment Alecensa has shown itself to be superior to Pfizer’s established rival Xalkori in a head-to-head trial as a first line treatment.
News Novartis' Zykadia gets fast first-line lung cancer review Roche rival has Breakthrough Therapy status.
News Novo sues Lilly over 'misleading' GLP-1 ad campaigning The rivalry between Novo Nordisk and Eli Lilly in the GLP-1 market has spilled over into the courts in the US, with claims of misleading advertising.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
